Background Current guidelines target low-density lipoprotein cholesterol (LDL-C)
concentrations to reduce atherosclerotic cardiovascular disease (ASCVD) risk, and yet …

The association between chronic inflammation and increased risk of cardiovascular disease
in rheumatoid arthritis (RA) is well established. In the general population, inflammation is an …

INTRODUCTION High-density lipoprotein (HDL) participates in cholesterol homeostasis and
may also have anti-inflammatory or anti-microbial roles through its interaction with numerous …

Background: Hypertriglyceridemia is associated with increased remnant-like particle
cholesterol (RLP-C) and triglycerides in low-density lipoprotein (LDL-TG). Recent studies …

The prothrombotic state in atrial fibrillation (AF) occurs as a result of multifaceted
interactions, known as Virchow's triad of hypercoagulability, structural abnormalities, and …

Residual cardiovascular disease event risk, following statin use and low-density lipoprotein
cholesterol (LDL-C) reduction, remains an important and common medical conundrum …

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease, of which the leading
cause of death is cardiovascular disease (CVD). The levels of total cholesterol (TC), low …

Background Elevation in small dense low-density lipoprotein (sdLDL) is common in patients
with diabetes mellitus (DM), which has already been reported to be associated with …

Although High Density Lipoprotein Cholesterol (HDL-C) levels are inversely proportional to
cardiovascular risk in many studies, recent pharmacological interventional studies with HDL …

Objective High-density lipoproteins (HDL) comprise particles of different size, density and
composition and their vasoprotective functions may differ. Diabetes modifies the composition …